Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer
Yu Bai, Daid Ahmad, Ting Wang, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 12, pp. 995-1004
Closed Access | Times Cited: 20

Showing 20 citing articles:

Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships
Ruo Wang, Huahong Chen, Weitao Yan, et al.
European Journal of Medicinal Chemistry (2020) Vol. 190, pp. 112109-112109
Closed Access | Times Cited: 165
Hidden pharmacological activities of valproic acid: A new insight
Dhirendra Kumar Singh, Sumeet Gupta, Inderjeet Verma, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112021-112021
Open Access | Times Cited: 72
A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid
Ayesha Safdar, Fátima Ismail
Saudi Pharmaceutical Journal (2022) Vol. 31, Iss. 2, pp. 265-278
Open Access | Times Cited: 41
Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
Kelly N. Hassell
Diseases (2019) Vol. 7, Iss. 4, pp. 57-57
Open Access | Times Cited: 53
A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy
Gist H. Farr, Melanie S. Morris, Arianna Gómez, et al.
Skeletal Muscle (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Discovery of YSR734: A Covalent HDAC Inhibitor with Cellular Activity in Acute Myeloid Leukemia and Duchenne Muscular Dystrophy
Yasir S. Raouf, Abootaleb Sedighi, Mulu Geletu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 16658-16679
Closed Access | Times Cited: 8
Silencing Lysine-Specific Histone Demethylase 1 (LSD1) Causes Increased HP1-Positive Chromatin, Stimulation of DNA Repair Processes, and Dysregulation of Proliferation by Chk1 Phosphorylation in Human Endothelial Cells
Martyna Wojtala, Arkadiusz Dąbek, Dorota Rybaczek, et al.
Cells (2019) Vol. 8, Iss. 10, pp. 1212-1212
Open Access | Times Cited: 23
Personalized Treatment Strategies via Integration of Gene Expression Biomarkers in Molecular Profiling of Laryngeal Cancer
Antonino Maniaci, Giovanni Giurdanella, Carlos M. Chiesa‐Estomba, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 10, pp. 1048-1048
Open Access | Times Cited: 2
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
Aaron Burmeister, Alexa Stephan, Leandro A. Alves Avelar, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 11, pp. 1674-1688
Open Access | Times Cited: 10
Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability
Changde Zhang, Shanchun Guo, Qiu Zhong, et al.
Pharmaceuticals (2019) Vol. 12, Iss. 4, pp. 180-180
Open Access | Times Cited: 12
Identification and Characterization of in vitro Metabolites of Belinostat by Rat Liver Microsomes using Ultra Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry
Parul Grover, Lovekesh Mehta, Tanveer Naved, et al.
Indian Journal of Pharmaceutical Education and Research (2022) Vol. 56, Iss. 1s, pp. s58-s66
Open Access | Times Cited: 6
Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status
Raúl A. Salazar‐González, Mark A. Doll, David W. Hein
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Degradation of Azo Dye by Ultrasound in Rotating Flow Field
Chunwei Shi, Fan Yang, Xiaogang Qu
Separations (2023) Vol. 10, Iss. 5, pp. 321-321
Open Access | Times Cited: 3
Novel ferrocene-pyrazolo[1,5-a]pyrimidine hybrids: A facile environment-friendly regioselective synthesis, structure elucidation, and their antioxidant, antibacterial, and anti-biofilm activities
Susma Das, Shivangi Borkotoky, MAXMILLANDO RYMBAI, et al.
Journal of Chemical Sciences (2022) Vol. 134, Iss. 3
Closed Access | Times Cited: 4
Epigenetic Regulation and Drug Discovery for Cancer Therapy
Bin Yu, Liang Ouyang
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 12, pp. 971-971
Closed Access | Times Cited: 5
Dual HDAC/BRD4 inhibitors against cancer
Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi
Medicinal Chemistry Research (2021) Vol. 30, Iss. 10, pp. 1822-1836
Closed Access | Times Cited: 5
Magnetic Hyperthermia Using Self-Controlled Heating Elements Consisting of Fe-Al Milling Alloy Induces Cancer Cell Apoptosis while Preserving Skeletal Muscle
Isao Kawahara, Kei Goto, Kenji Kodama, et al.
Pathobiology (2019) Vol. 86, Iss. 5-6, pp. 254-262
Open Access | Times Cited: 4
A CTCF-Binding Element and Histone Deacetylation Cooperatively Maintain Chromatin Loops, Linking to Long-Range Gene Regulation in Cancer Genomes
Ran Tang, Yiqun Li, Fang Han, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 2
Butyrate: A Review on Beneficial Pharmacological and Therapeutic Effect
Dhirendra Singh, Sumeet Gupta
Current Nutrition & Food Science (2020) Vol. 17, Iss. 5, pp. 470-482
Closed Access | Times Cited: 1
A novel drug-combination screen in zebrafish identifies epigenetic small molecule candidates for Duchenne muscular dystrophy
Gist H. Farr, Melanie S. Morris, Arianna Gómez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access
Page 1

Scroll to top